Muscle Pharm Corporation (MSLPQ)

[jeff_green]

PJ, My statement is 100% factual. Here is a transcript excerpt from the Q3 conference call referencing a decline in revenue in MSLP's largest sales channel; specialty. Go back an read my post in detail and revenues in all channels are declining in the core business of MSLP product. Remember this comment was made referencing Q3 that reported $47m in revenue but $7m of that revenue was smoke and mirrors bargain purchase gain based on intangible assets that was somehow reported as operating income and not a balance sheet item. NOT GAAP. So MSLP really did $40m in rev and if you strip out the BZNE $2m then you get $38m from core ops. MSLP has 4 quarters in row of decline real revenue from core operations of MSLP products. Q4 drop was dramatic but there has been a trend for a while now and YOY quarterly comp numbers are now showing a decline.

Brad J. Pyatt - President and Chief Executive Officer
Good morning.

Joseph A. Gomes - William Smith & Co.
Just can you give us a little insight here, during the quarter the specialty distribution channel actually declined in revenues and I just wonder if you can kind of gives us a little bit more insight as to what’s going on there in that channel?

Brad J. Pyatt - President and Chief Executive Officer
Richard, go ahead and answer that one.